97 related articles for article (PubMed ID: 30922918)
1. A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Maggio V; Cánovas V; Félix AJ; Gómez V; de Torres I; Semidey ME; Morote J; Noé V; Ciudad CJ; Paciucci R
Cancer Lett; 2019 Jun; 452():158-167. PubMed ID: 30922918
[TBL] [Abstract][Full Text] [Related]
2. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
Cánovas V; Puñal Y; Maggio V; Redondo E; Marín M; Mellado B; Olivan M; Lleonart M; Planas J; Morote J; Paciucci R
Oncotarget; 2017 Aug; 8(35):59165-59180. PubMed ID: 28938627
[TBL] [Abstract][Full Text] [Related]
3. The role of prostate tumor overexpressed 1 in cancer progression.
Cánovas V; Lleonart M; Morote J; Paciucci R
Oncotarget; 2017 Feb; 8(7):12451-12471. PubMed ID: 28029646
[TBL] [Abstract][Full Text] [Related]
4. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
5. The extended AT-hook is a novel RNA binding motif.
Filarsky M; Zillner K; Araya I; Villar-Garea A; Merkl R; Längst G; Németh A
RNA Biol; 2015; 12(8):864-76. PubMed ID: 26156556
[TBL] [Abstract][Full Text] [Related]
6. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1.
Marqués N; Sesé M; Cánovas V; Valente F; Bermudo R; de Torres I; Fernández Y; Abasolo I; Fernández PL; Contreras H; Castellón E; Celià-Terrassa T; Méndez R; Ramón Y Cajal S; Thomson TM; Paciucci R
Oncogene; 2014 Feb; 33(9):1124-34. PubMed ID: 23455324
[TBL] [Abstract][Full Text] [Related]
7. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Yoshino J; Akiyama Y; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Carcinogenesis; 2020 Jul; 41(6):734-742. PubMed ID: 31665232
[TBL] [Abstract][Full Text] [Related]
8. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle.
Santamaría A; Fernández PL; Farré X; Benedit P; Reventós J; Morote J; Paciucci R; Thomson TM
Am J Pathol; 2003 Mar; 162(3):897-905. PubMed ID: 12598323
[TBL] [Abstract][Full Text] [Related]
9. Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
Rausch S; Hennenlotter J; Scharpf M; Teepe K; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
J Cancer Res Clin Oncol; 2016 May; 142(5):937-47. PubMed ID: 26746655
[TBL] [Abstract][Full Text] [Related]
10. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
11. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
13. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.
Benedit P; Paciucci R; Thomson TM; Valeri M; Nadal M; Càceres C; de Torres I; Estivill X; Lozano JJ; Morote J; Reventós J
Oncogene; 2001 Mar; 20(12):1455-64. PubMed ID: 11313889
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
[TBL] [Abstract][Full Text] [Related]
15. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
16. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
Fu G; Peng C
Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
[TBL] [Abstract][Full Text] [Related]
17. Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling.
Cui Y; Ma W; Lei F; Li Q; Su Y; Lin X; Lin C; Zhang X; Ye L; Wu S; Li J; Yuan Z; Song L
J Pathol; 2016 Jul; 239(3):297-308. PubMed ID: 27060981
[TBL] [Abstract][Full Text] [Related]
18. PTOV1 is overexpressed in human high-grade malignant tumors.
Fernández S; Mosquera JL; Alaña L; Sanchez-Pla A; Morote J; Ramón Y Cajal S; Reventós J; de Torres I; Paciucci R
Virchows Arch; 2011 Mar; 458(3):323-30. PubMed ID: 21181414
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.
Cui DW; Cheng YJ; Jing SW; Sun GG
Tumour Biol; 2014 Apr; 35(4):3017-24. PubMed ID: 24293374
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells.
Karna SKL; Ahmad F; Lone BA; Pokharel YR
PLoS One; 2019; 14(5):e0211658. PubMed ID: 31083670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
